Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

Bristol Myers Squibb works with SpaceX to study biomanufacturing in space

March 16, 2023 Medical Communications

It was announced last week that the SpaceX Dragon spacecraft will make its journey to the International Space Station (ISS) …
News

Cough medicines containing pholcodine withdrawn across UK

March 15, 2023 Medical Communications

Some cough syrups being sold behind the counter at pharmacies are being withdrawn due to safety concerns surrounding potential allergies …
News

FDA amends EUA of Pfizer-BioNTech COVID-19 vaccine for paediatric use

March 15, 2023 Medical Communications

Yesterday, the FDA announced that it has amended the Emergency Use Authorization (EUA) for the Pfizer-BioNTech bivalent COVID-19 Vaccine. The …
News

BlueRock Therapeutics collaboration over Parkinson’s disease digital health technology

March 15, 2023 Medical Communications

Clinical stage biopharmaceutical company BlueRock Therapeutics has announced a collaboration with Rune Labs and Emerald Innovations. It will look at …
News

US bill pushes Medicare and Medicaid categories for prescription digital therapeutics

March 14, 2023 Medical Communications

Both the US House of Representatives and Senate are considering a bill which would encourage the adoption of prescription digital …
News

Nasal spray that relieves migraines in minutes approved by FDA

March 13, 2023 Medical Communications

Pfizer is planning to launch a fast-acting nasal spray that can relieve pain from migraines in as little as 15 …
News

Horizon Therapeutics announces real-world treatment results for Dysthyroid Optic Neuropathy drug

March 13, 2023 Medical Communications

Biopharma company Horizon Therapeutics has announced real-world treatment results for its Thyroid Eye Disease (TED) drug in patients with Dysthyroid …
News

Biotech centre focusing on gene therapies opens in Bristol, UK

March 10, 2023 Medical Communications

A new state-of-the-art facility named the Clinical Biotechnology Centre (CBC) is opening in Bristol, UK. It cost approximately £10m to …
News

FDA committee supports Roche’s lymphoma treatment

March 10, 2023 Medical Communications

 A committee at the FDA have voted in favour of Roche’s Polivy antibody drug targeting untreated diffuse large B cell …
News

Respiree gets FDA clearance for cardio-respiratory wearable

March 9, 2023 Medical Communications

Respiree, a digital therapeutics start-up, has secured the 510(k) FDA clearance for its RS001 cardio-respiratory wearable.   RS001 is a …
News

Abbott’s concussion-detecting blood test approved by FDA

March 8, 2023 Medical Communications

US-based Abbott, a medical technology company, has received FDA approval for its laboratory blood test which detects traumatic brain injury …
News

Hospital for Special Surgery reveals 3D surface topographic scan for scoliosis patients

March 8, 2023 Medical Communications

Researchers at New York City’s Hospital for Special Surgery (HSS) have found that using a 30-camera array, or 3dMD, can …
News

FDA grants de novo approval to Neuromod’s tinnitus device

March 8, 2023 Medical Communications

The FDA has granted de novo approval to Neuromod’s Lenire device which includes Bluetooth headphones, a handheld controller and the …
News

BioMarin receives FDA update for gene therapy for adults with severe haemophilia A

March 7, 2023 Medical Communications

Global biotechnology company BioMarin Pharmaceutical has announced that it’s received an update from the FDA, detailing the extension of their …
News

Sooma receives FDA Breakthrough Device designation for depression therapy device

March 7, 2023 Medical Communications

Finnish company Sooma Medical has received Breakthrough Device designation by the FDA for its portable, at-home neuromodulation device to treat …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025